McKesson (BSP:M1CK34) Beta: -0.2507 (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:M1CK34 McKesson Corp BSP:M1CK34
83 GF Score
Price R$1,086.09
GF Value R$1,018.13
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is McKesson Beta?

McKesson BSP:M1CK34 +1.90% 83 Beta is -0.2507 as of Jul. 18, 2026. GuruFocus rates BSP:M1CK34 with a GF Score™ of 83/100 and a GF Value™ of R$1,018.13 (Fairly Valued). The stock has 2 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-18), McKesson's Beta is -0.2507.


McKesson  (BSP:M1CK34) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


McKesson Beta Related Terms


McKesson Beta Historical Data

* Premium members only.

The historical data trend for McKesson's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

McKesson Beta Chart

McKesson Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.01 -0.27 -0.28 -0.25

McKesson Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.28 -0.17 -0.18 -0.22 -0.25

BSP:M1CK34 vs CAH, COR, HSIC: Beta Comparison

For the Medical Distribution subindustry, McKesson's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


McKesson Beta vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, McKesson's Beta distribution charts can be found below:

* The bar in red indicates where McKesson's Beta falls into.


BSP:M1CK34
83GF Score
McKesson Corp BSP:M1CK34
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

McKesson Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.2507 mean?
McKesson (BSP:M1CK34) has a Beta of -0.2507 as of Jul. 18, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for McKesson and its competitors.
Is McKesson's Beta too high?
McKesson's current Beta is -0.2507. Overall, McKesson has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does McKesson's Beta compare to CAH and COR?
McKesson's Beta of -0.2507 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Distribution company?
A good Beta depends on the Medical Distribution industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for McKesson and its competitors. McKesson's current Beta is -0.2507. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is McKesson stock overvalued right now?
Based on GuruFocus' analysis, McKesson (BSP:M1CK34) is currently considered Fairly Valued. The stock's GF Value™ is R$1,018.13, compared to a current price of R$1,086.09 — trading 6.7% above its estimated fair value. The current Beta is -0.2507. McKesson's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For McKesson (BSP:M1CK34), the current Beta is -0.2507 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is McKesson (BSP:M1CK34) Overvalued in 2026?

Based on GuruFocus' analysis, McKesson stock appears to be overvalued. The current stock price of R$1,086.09 is trading 6.7% above its estimated GF Value™ of R$1,018.13. GuruFocus considers McKesson to be Fairly Valued.

Key valuation signals for BSP:M1CK34:

  • Beta: -0.2507
  • GF Value™: R$1,018.13 vs. price of R$1,086.09 (6.7% above fair value)
  • GF Score™: 83/100 with 2 warning signs

No single metric tells the full story. See the BSP:M1CK34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


McKesson Business Description

Address 6555 State Highway 161, Irving, TX, USA, 75039
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
83GF Score

Get the complete analysis for BSP:M1CK34

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$1,086.09
Price
R$1,018.13
GF Value